Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy

The study of immune evasion has gained a well-deserved eminence in cancer research by successfully developing a new class of therapeutics, immune checkpoint inhibitors, such as pembrolizumab and nivolumab, anti-PD-1 antibodies. By aiming at the immune checkpoint blockade (ICB), these new therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkatraman, Simran, Meller, Jarek, Hongeng, Suradej, Tohtong, Rutaiwan, Chutipongtanate, Somchai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761936/
https://www.ncbi.nlm.nih.gov/pubmed/33291616
http://dx.doi.org/10.3390/vaccines8040735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761936/
https://www.ncbi.nlm.nih.gov/pubmed/33291616
http://dx.doi.org/10.3390/vaccines8040735

Ejemplares similares